Original Post by PharmaPro (2 hours ago):
Zydus crushed earnings with 15% revenue growth, shares popping 2%! US generics driving it. Whole pharma sector up 1.5% today. Sun Pharma next? I'm buying on dips - healthcare's defensive in volatile times. What's your pharma portfolio look like?
Reply by MedStockFan (45 mins ago):
Zydus is gem! Added at 1,200 last quarter. Dr Reddy's undervalued too. Rally to 28k Nifty could push it to 1,500.
Reply by BearPharma (20 mins ago):
Beat yes, but pricing pressures from US FDA. Hold, don't chase. Diversify to Cipla.